Dec
21
Joyful holidays!
Science moves forward through collaboration, curiosity, and commitment. We are grateful for the colleagues, partners, and collaborators who contributed to
Latest
Dec
18
Finally published PBA-0405 data!
Frontiers | A novel fully human anti-ROR1 antibody PBA-0405 optimized for ADCC, induces potent anti-tumor activity against both solid and hematological
1 min read
Jan
16
Email issues
Zermatt consulting has experience e-mail delivery issues, we apologize for the inconvenience. The issues should now be resolved and you
Jan
01
Happy New Year 2025
We are thanking all customers, and co-laboraters for the year 2024 and wishing health, happiness and new success stories for
Dec
19
Happy holidays
Warm holiday wishes🎄 As we begin to look ahead to 2025, we wish you a joyful holiday season. May this
Sep
13
We have soon capacity for new co-laboration opportunities
We can support your drug development, discovery, in vitro and in vivo research, CRO contacts, support regulatory submission, people management,
Sep
10
First indication of PBA-0405 activity in patient settings
Pure Biologics released first biomarker data obtained in Phase O clinical study in Head and Neck patients receiving intra-tumoral injection
1 min read
Jul
16
PBA-0111 received "Study may proceed" letter from FDA
Pure Biologics took another significant step forward by receiving a "study may proceed" letter from the US Food
1 min read
Jul
15
First patient dosed with PBA-0405
Pure Biologics announced on July 15, 2024 the dosing of the first patient was with the candidate PBA-0405 in a
1 min read
Feb
25
Coming more soon
This is Zermatt Consulting, a brand new site that's just getting started. Things will be up and running